Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States.
Christine L BakerAmol D DhamaneJack MardekianOluwaseyi DinaCristina RussLisa RosenblattMelissa Lingohr-SmithBrandy MengesJay LinAnagha NadkarniPublished in: Advances in therapy (2018)
Pfizer and Bristol-Myers Squibb.